43 articles with Swift Biosciences
Genemarkers LLC & Swift Biosciences Detect Unexpected Variant from COVID-19 S Gene Dropout Samples from Kalamazoo, MI
Genemarkers LLC, leaders in genomic research from Kalamazoo, MI and Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing systems in Ann Arbor, MI, collaborated together to detect mutations and variants from COVID-19 samples sourced in Kalamazoo, MI.
- A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces the addition of Bruce Zhang , Director of Sales and Marketing, APAC to its global commercial team. Bruce comes to Swift with ten years of rich experience and has led efforts in increa
Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits introduces the new Swift 2S Sonic DNA Library Kit to the NGS Industry. After a tremendously successful debut of Swift 2S Turbo 's low-cost enzymatic fra
Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test
Swift Biosciences, a leader in Next-Generation Sequencing Manufacturing & Technology and BillionToOne, a precision diagnostics company today announced that Swift Bioscience will be the exclusive distributor of BillionToOne's RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity testing of up to a million tests per day.
Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to prov
COVID-19 Research Race Shows Importance of Speed, Precision & Efficiency in Genomic Sequencing in Fighting both New and Established Diseases
Swift Biosciences, a leader in Next-Generation Sequencing Technology lays the groundwork for emerging research into common and rare disease as well as novel infectious disease.
Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has signed an agreement to supply its Swift 2S® Turbo DNA Library Kits to Otogenetics Corporation, a high throughput NGS clinical lab offering Prenatal Testing, Deafness Testing, Hereditary Cancer
Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift's
Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift's assay enables resea
Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), announced the release of its Swift Amplicon SARS-CoV-2 Research Panel. Targeting the full viral genome in a single reaction with a rapid 2-hour workflow, Swift's assay meets research and surveillance need
ANN ARBOR, Mich. , Feb. 24, 2020 /PRNewswire/ -- Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), today announced a partnership agreement with LGC, Biosearch Technologies, a global leader in specialty genomic analysis tools to leverage Swift's targeted sequencing technology into LGC Biosearch T
Swift Biosciences, Inc ("Swift") and Helix OpCo, LLC ("Helix") today announced a Partnership Agreement to leverage Swift's 2S™ Turbo DNA library preparation for Helix's Exome+™ assay.
Opentrons Labworks and Swift Bioscience Launch "Plug-Play" NGS Library Preparation Automation Workstation
Opentrons Labworks, Inc. (“Opentrons”) and Swift Biosciences, Inc. (“Swift”) announce the launch of the most affordable fully-automated workstation for next-generation sequencing (NGS) library preparation ever put on the market.
Swift Biosciences and Opentrons Partner to Provide a Turnkey Automated NGS Library Preparation Workflow
Swift Biosciences, Inc ("Swift") and Opentrons Labworks, Inc. ("Opentrons") today at the SLAS2020 conference announce their partnership to leverage Swift's efficient NGS library preparation kits on Opentrons' open-source automation platform.
Swift Biosciences, Inc. ("Swift"), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift's DNA and RNA library preparation products in Europe and Asia Pacific markets.
Swift Biosciences Launches Normalase™, Radically Streamlining and Improving NGS Library Normalization
Swift Biosciences today announced availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation
Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident, Targeted Detection of Low Frequency Variants from Liquid Biopsy Sequencing
Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA).
Swift Biosciences, today named industry veteran Nathan Wood as its new CEO.
New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening
Swift Biosciences Launches Unique Dual Indexing Kits to Improve Multiplexed Next Generation Sequencing
New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results